Genomes.io Secures $20m Investment to Advance DNA Data Storage
Genomes.io, a London-based biotech company, has recently received a commitment of USD20m from GEM Digital Limited, a digital asset investment firm based in the Bahamas. This investment will greatly accelerate Genomes.io's technological growth and enable them to further develop their secure DNA data storage and sharing application. The company, founded in 2018 by Aldo de Pape, CEO, focuses on the safe, private, and auditable monetization of genomic data.
Genomes.
.io's platform allows users to sequence, store, and commercialize their genomic data while ensuring its security and privacy. Moreover, it enables biotech and pharmaceutical organizations to access genomic data in an equitable manner. Since its establishment, the company has been committed to developing its infrastructure by partnering with industry leaders such as AMD and ConsenSys. These collaborations aim to guarantee the safe storage, querying, and management of genomic data, addressing concerns surrounding data privacy and security.
The recognition and success of Genomes.io are evident from its recent achievements. In 2022, the company was honored with the Deloitte Tech Fast 50 Challenge Award, acknowledging its innovation and disruptiveness in the healthcare sector, particularly in the field of Web3 technology. Additionally, Genomes.io has taken a proactive approach towards supporting scientific research. It recently compensated its vault holders to advance genomic insights into long COVID in an anonymous manner, showcasing its commitment to advancing medical knowledge and benefiting society as a whole.
They've invested in Genomes.io
Get to know these Healthtech investors
Click here for a full list of 6,908+ startup investors in the UK